Granite Bay Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Granite Bay Wealth Management's ABBV Position: Q1 2024 in Review
Granite Bay Wealth Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 19,505 shares — an estimated $2.81M sold.
Granite Bay Wealth Management first reported a position in ABBV in Q3 2023 and held it in 2 quarters. The position peaked at $3.56M in Q3 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Granite Bay Wealth Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
- Granite Bay Wealth Management sold 19,505 AbbVie shares in Q1 2024, an estimated $2.81M.
- Granite Bay Wealth Management first reported a position in AbbVie in Q3 2023 and held it in 2 quarters.
- Granite Bay Wealth Management's AbbVie position peaked at $3.56M in Q3 2023.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.